An international study published in the journal Nature Mental Health has identified three psychological profiles associated ...

Anavex's financial health is stable with cash runway into 2028, but rising expenses are expected. Click here to find out why ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Omega-3 fatty acids are a type of essential fats linked to many health benefits, such as heart health, reduced inflammation, ...

Alpha Cognition (ACOG) announced the strategic appointments of Jen Pesa, Vice President of Commercial; Jack Kelly, Head of Market Access; ...

Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to ...

Researchers have assessed the human perception of the size and weight of body parts, specifically the hand, comparing it to the perception of objects ...

Ultragenyx will present at the 43ᵗʰ annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 AM PT. The live and archived webcast of the presentation will be accessible from the ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Virbac said that URSOLYX Soft Chews targets mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic ...

The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...